SO THERAPIES
ActiveSO THERAPIES has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2k and a net result of €5k. Equity is growing by ~82.2% per year across the filed fiscal years. Its solvency ranks better than 43% of 2042 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
82
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+39
Solvency59▲+59
Growth78=
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 85
Relative position
BE, all sectors
reference
Sector 85
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
18 d early
2024
19 d late
2023
29 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€2k
2024 · €-3k
2023: €-3k
2024: €-3k
2023 → 2025
Total assets
€6k▲ 472%
2024 · €1k
2023: €19
2024: €1k
2023 → 2025
Net result
€5k▲ 5,358%
2024 · €99
2023: €-4k
2024: €99
2023 → 2025
Working capital
€2k
2024 · €-3k
2023: €-3k
2024: €-3k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€-3k-€-3k▲ 2.9%€2k
Operating result€-4k-€150€6k▲ 3,767%
Net result€-4k-€99€5k▲ 5,358%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 3,767% above 2024 and is the highest result in the available series.
Balance-sheet composition
Equity and liabilities €6k
Equity
€2k
Debt
€4k
Debt finances 65.6% of the balance-sheet total.
Key figures and ratios
Solvency
34.4%
Current ratio
1.52
Quick ratio
1.52
Debt / equity
1.91
ROE
263.0%
ROA
90.5%
Debt
€4k▼
2024 · €4k
Debt ≤ 1 year
€4k▼
2024 · €4k
Income taxes
€341
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1k€6k▲
Current assets29/58€1k€6k▲
Amounts receivable within one year40/41€1k€168▼
Trade receivables40€800-
Other amounts receivable41€242€168▼
Cash at bank and in hand54/58€1€6k▲
Equity and liabilities
Total equity and liabilities10/49€1k€6k▲
Equity10/15€-3k€2k▲
Contributions10/11€1k€1k=
Profit (loss) carried forward14€-4k€1k▲
Amounts payable17/49€4k€4k▼
Amounts payable within one year42/48€4k€4k▼
Trade debts44€1k€363▼
Suppliers440/4€1k€363▼
Taxes, remuneration and social security45-€341
Taxes450/3-€341
Other amounts payable47/48€3k€3k▲
Income statement
Code20242025
Gross operating margin9900€150€6k▲
Operating profit (loss)9901€150€6k▲
Financial charges65/66B€51€61▲
Recurring financial charges65€51€61▲
Profit (loss) for the period before taxes9903€99€6k▲
Income taxes67/77-€341
Profit (loss) for the period9904€99€5k▲
Profit (loss) for the period to be appropriated9905€99€5k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-4k€1k▲
Profit (loss) brought forward from the previous period14P€-4k€-4k▲
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €5k ▲5358%
Operating result €6k, net result €5k, both a record.
31-12
Financial
Liquidity times 6current ratio 1.52
Current ratio from 0.24 to 1.52; short-term debt falls from €4k to €4k.
19-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 19 days late
2024
31-12
Financial
Back to profitnet €99
Net result €99 after one loss-making year.
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Batticelaan 321932 ZaventemGround area
8,971 m²
Building footprint
401 m²
Volume, LiDAR
6,307 m³
Parcel 23078B0296/00P000, Flanders · tallest building 20.0 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
SO THERAPIES
since 20222.337.539.355
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23078B0296/00P000 | Flanders | 8,971 m² | 1 · 401 m² | 20.0 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MEHELIT
BE 0644.758.901
Courcelles · Eq €2k
17 DAYS
BE 0757.566.535
Hasselt · Eq €2k
J-CONSULT
BE 0475.518.843
Elsene · Eq €2k
COMPLIANCE4BUSINESS GROUP
BE 0753.897.262
Lasne · Eq €2k
Anythink
BE 0780.903.844
Schaarbeek · Eq €2k
Of 11,670 companies in sector 85599 we hold annual accounts for 1,329. 343 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-10-2022
Fiscal year end31-12
Activities, NACEBEL
85599Other education
86909Human health activities
86995Nutrition and dietetics services
96999Other personal services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.